Interferon-beta-1b-induced short- and long-term signatures of treatment activity in multiple sclerosis.
Interferon-beta-1b-induced short- and long-term signatures of treatment activity in multiple sclerosis. Pharmacogenomics J. 2013 Oct; 13(5):443-51.